Osteosarcoma immunotherapy study has potential to benefit both dogs, humans

Osteosarcoma is a highly aggressive bone tumor that affects at least 10,000 dogs annually in the United States. It is most commonly seen in the adult large and giant breeds such as Rottweilers, Labrador retrievers, greyhounds, Newfoundlands, Irish wolfhounds, Great Danes and Scottish deerhounds. “Since dogs with osteosarcoma represent spontaneous bona-fide model of the same disease in children, it is likely that the same approach will provide significant survival benefits in children with the same disease,” one researcher commented.